Atwood & Palmer’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-665
Closed -$20K 423
2021
Q1
$20K Hold
665
﹤0.01% 294
2020
Q4
$21K Buy
+665
New +$21K ﹤0.01% 272